April 17, 2014
The International Medication Safety Network makes recommendations as part of a comprehensive, worldwide solution to the problem of unsafe medicines naming, labelling and packaging.
The International Medication Safety Network makes recommendations as part of a comprehensive, worldwide solution to the problem of unsafe medicines naming, labelling and packaging.  
Download PDF

Summary: At a satellite conference held in Paris, France during the International Medication Safety Network meeting on Thursday October 10, 2013, representatives from over 20 countries gave their support for a proposal that regulators and other stakeholders join IMSN at a summit in 2014 to address   ...... 
At a satellite conference held in Paris, France during the International Medication Safety Network meeting on Thursday October 10, 2013, representatives from over 20 countries gave their support for a proposal that regulators and other stakeholders join IMSN at a summit in 2014 to address the global threat to patient safety caused by unsafe medicine naming, labeling and packaging.   
Download PDF

The 8th annual meeting of the International Medication Safety Network will be held on October 11 & 12, 2013 in Paris, France. An International Conference on safer naming, labelling and packaging of medications will be held on October 10.
The 8th annual meeting of the International Medication Safety Network will be held on October 11 & 12, 2013 in Paris, France. An International Conference on safer naming, labelling and packaging of medications will be held on October 10.   
Download PDF

On February 22, 2013, the US Food and Drug Administration (FDA)approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists. Click link above for more information.
On February 22, 2013, the US Food and Drug Administration (FDA)approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists. Click link above for more information.  

The Seventh Annual Meeting of the International Medication Safety Network was held on November 17 & 18, 2012.
The Seventh Annual Meeting of the International Medication Safety Network was held on November 17 & 18, 2012.  

Summary: The Institute for Safe Medication Practices (ISMP), which operates the National Medication Errors Reporting Program, is warning healthcare providers about repeated incidents of accidental application of “glacial” acetic acid (= 99.5%) to skin or mucous membranes instead of a much more   ...... 
The Institute for Safe Medication Practices (ISMP), which operates the National Medication Errors Reporting Program, is warning healthcare providers about repeated incidents of accidental application of “glacial” acetic acid (= 99.5%) to skin or mucous membranes instead of a much more diluted form. Glacial acetic acid is the most concentrated form of acetic acid available. Inadvertent application of this corrosive chemical has led to severe burns, scarring, and other permanent damage to skin or mucous membranes. Click link above for more information.  

Summary: The 2012 ISMP International Medication Safety Self Assessment® for Oncology was developed by the Institute for Safe Medication Practices (ISMP) and the Institute for Safe Medication Practices Canada (ISMP Canada), through a grant from the International Society of Oncology Pharmacy   ...... 
The 2012 ISMP International Medication Safety Self Assessment® for Oncology was developed by the Institute for Safe Medication Practices (ISMP) and the Institute for Safe Medication Practices Canada (ISMP Canada), through a grant from the International Society of Oncology Pharmacy Practitioners (ISOPP) to help hospitals and ambulatory care centers throughout the world evaluate oncology medication safety. Chemotherapy and biotherapy agents used in cancer treatment are considered to be "high-alert" drugs which are more likely to cause patient harm when involved in an error. The self assessment is designed to heighten awareness of the distinguishing characteristics of a safe medication system, with a specific focus on management of chemotherapy, biotherapy, and treatment-related drugs.  

The Sixth Annual IMSN meeting was held on November 4-5, 2011 in Hong Kong.
The Sixth Annual IMSN meeting was held on November 4-5, 2011 in Hong Kong.   

Summary: A loading dose is an initial large dose of a medicine used to ensure a quick therapeutic response. It is usually given for a short period before therapy continues with a lower maintenance dose. The use of loading doses of medicines can be complex and error prone. Incorrect use of loading   ...... 
A loading dose is an initial large dose of a medicine used to ensure a quick therapeutic response. It is usually given for a short period before therapy continues with a lower maintenance dose. The use of loading doses of medicines can be complex and error prone. Incorrect use of loading doses or subsequent maintenance regimens may lead to severe harm or death. The National Patient Safety Agency in the UK has issued a guidance to prevent harms from oral and injectable loading doses in hospitals and in the community.  

Summary: The term ‘anti-cancer medicines’ includes conventional cytotoxic and cytostatic medicines, as well as newer biological treatments such as monoclonal antibodies, so-called ‘small molecules’, and other targeted therapies. The national Patient Safety Agency in the UK review 4,829 incident   ...... 
The term ‘anti-cancer medicines’ includes conventional cytotoxic and cytostatic medicines, as well as newer biological treatments such as monoclonal antibodies, so-called ‘small molecules’, and other targeted therapies. The national Patient Safety Agency in the UK review 4,829 incident reports reported between 1 November 2003 and 30 June 2008 and identified common causes of error with these medicines and ways that these risks can be better managed.  

Summary: Health care systems around the world require mandatory training for health care professionals on a range of topics including basic life support, fire safety and lifting and handling of patients. The IMSN has developed a course curriculum and support materials for a Basic Medication   ...... 
Health care systems around the world require mandatory training for health care professionals on a range of topics including basic life support, fire safety and lifting and handling of patients. The IMSN has developed a course curriculum and support materials for a Basic Medication Safety Course (see resources section of this web site). The course is designed to raise awareness of the frequency and types of medication errors, why they occur and methods to minimise the risk of harm to patients. The course is designed to be delivered in 4 – 5 hours. Dr Mubashar Kharal, Chairman, Medication Safety Program, and Amjed Abualburak, Nurse Trainer, Saud Bin Abdul Aziz University for Health Sciences, National Guard Health Affairs, Saudi Arabia have successfully delivered BMS courses to hundreds of doctors nurses and pharmacists in hospitals within their health system. ISMN is promoting BMS courses for use in health care systems in other countries to help minimise preventable harms from medicines. Organisations can obtain accreditation as an ISMN course provider. Contact ISMN for more information.   
Download PDF

Summary: The International Medication Safety Network is currently reviewing "A guide to labelling and packaging of injectable medicines" as well as other documents in preparation for IMSN international recommendations for safe labeling of injectable drugs. Should you have suggestions of your own,   ...... 
The International Medication Safety Network is currently reviewing "A guide to labelling and packaging of injectable medicines" as well as other documents in preparation for IMSN international recommendations for safe labeling of injectable drugs. Should you have suggestions of your own, we would be pleased to accept them for consideration. Please forward to the IMSN Chair via IMSN Headquarters (see contact information at bottom of this web page).   
Download PDF

Summary: The latest publication from the National Patient Safety Agency's Design For Patient Safety Series - concerning the safe design of onscreen display of medicines information. This information may be of value to you for electronic prescribing and pharmacy systems that use medicines   ...... 
The latest publication from the National Patient Safety Agency's Design For Patient Safety Series - concerning the safe design of onscreen display of medicines information. This information may be of value to you for electronic prescribing and pharmacy systems that use medicines information.   
Download PDF